Malta - angleščina - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - granules for oral suspension - cefuroxime 250 mg/5ml - antibacterials for systemic use

Malta - angleščina - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - granules for oral suspension - cefuroxime 125 mg/5ml - antibacterials for systemic use

Malta - angleščina - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - cefuroxime - granules for oral suspension - cefuroxime 250 milligram(s)/5 millilitre - antibacterials for systemic use

Malta - angleščina - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - cefuroxime - granules for oral suspension - cefuroxime 125 milligram(s)/5 millilitre - antibacterials for systemic use

Irska - angleščina - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - oxfendazole - oral suspension - 2.265 %w/v - oxfendazole - bovine, ovine - endoparasiticide

Irska - angleščina - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - oxfendazole - oral suspension - 9.06 %w/v - oxfendazole - bovine, ovine - endoparasiticide

Velika Britanija - angleščina - VMD (Veterinary Medicines Directorate)

norbrook laboratories limited - cobalt, oxfendazole - oral suspension - anthelmintic anticestodal - sheep

Singapur - angleščina - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - carbamazepine - suspension - 2 g/100 ml - carbamazepine 2 g/100 ml

Združene države Amerike - angleščina - NLM (National Library of Medicine)

lannett company, inc. - nystatin (unii: bdf1o1c72e) (nystatin - unii:bdf1o1c72e) - nystatin oral suspension is indicated for the treatment of candidiasis in the oral cavity. the preparation is contraindicated in patients with a history of hypersensitivity to any of its components.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - nystatin (unii: bdf1o1c72e) (nystatin - unii:bdf1o1c72e) - nystatin oral suspension is indicated for the treatment of candidiasis in the oral cavity. the preparation is contraindicated in patients with a history of hypersensitivity to any of its components.